Stavros G. Vizirgianakis's Net Worth
$19.2 Million
Who is Stavros G. Vizirgianakis?
Stavros G. Vizirgianakis has an estimated net worth of $19.2 Million. This is based on reported shares across multiple companies, which include Bioventus Inc., Xtant Medical Holdings, Inc., and MISONIX INC.
SEC CIK
Stavros G. Vizirgianakis's CIK is 0001559834
Past Insider Trading and Trends
2021 was Stavros G. Vizirgianakis's most active year for acquiring shares with 10 total transactions. Stavros G. Vizirgianakis's most active month to acquire stocks was the month of September. 2016 was Stavros G. Vizirgianakis's most active year for disposing of shares, totalling 2 transactions. Stavros G. Vizirgianakis's most active month to dispose stocks was the month of August. 2016 saw Stavros G. Vizirgianakis paying a total of $4,140,846.66 for 1,198,969 shares, this is the most they've acquired in one year. In 2021 Stavros G. Vizirgianakis cashed out on 2,136,478 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bioventus Inc. (BVS) Snapshot price: $4.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.03% | 965 |
—
|
—
| 2.78M |
Jun 16 - Jun 17
| |||
Form 4
|
∞
| 2.78M |
—
|
—
| 2.78M |
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xtant Medical Holdings, Inc. (XTNT) Snapshot price: $1.045
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.63% | 217.77K |
—
|
—
| 6.21M |
Aug 15
| |||
Form 4
| +2.47% | 144.64K |
—
|
—
| 6M |
Nov 15
| |||
Form 4
| +63.16% | 2.26M |
$0.48 | $1,087,133.28 | 5.85M |
Oct 7
| |||
Form 4
| +2.01% | 70.78K |
—
|
—
| 3.59M |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MISONIX INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.14M |
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| +0.61% | 10K |
$9.84 | $98,400.00 | 1.65M |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 4
| +0.46% | 7.5K |
$6.96 | $52,162.50 | 1.64M |
Sep 21
| |||
Form 4
| +1.40% | 22.5K |
$6.26 | $140,850.00 | 1.63M |
Dec 21
| |||
Form 4
| +33.03% | 400K |
—
|
—
| 1.61M |
Dec 15
| |||
Form 4
| +169.36% | 761.47K |
$5.25 | $3,999,996.66 | 1.21M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +18.29% | 69.51K |
$5.70 | $396,201.30 | 449.61K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apyx Medical Corp (APYX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||